
Are you a cigarette smoker looking to quit?
Take the next step in your quit journey. See if the SUMMIT study for smoking cessation is right for you.
Who Can Participate?
The SUMMIT study is looking for adults who*:
- Are ages 18-65
- Smoke, on average, 10 or more cigarettes per day
- Have smoked regularly over the past year
- Want to quit smoking and are willing to set a quit date
- Are willing to complete a daily smoking diary during the study

How Can I Participate?
Step 1
Complete the online questionnaire here to see if you may be eligible.
Step 2
If you meet certain conditions and want to learn more, your information will be sent to a study site near you.
Step 3
Study site staff will contact you to talk more about the study and get more information on your health history. You may be invited to the study site for a first visit.
Step 4
At the study site, the study doctor and their team will talk to you about participation in the study. After you have asked all of your questions, you will be asked to sign a consent form.
Click the button below to fill out a quick form to see if you may be eligible for the SUMMIT study.
By filling out this form, you are under no obligation to participate in the study. Your information will be forwarded to the study site closest to you where a member of the staff will reach out via phone, email, or text to collect more information.
About the Study
The SUMMIT study is looking at the effectiveness and safety of an investigational medication called AXS-05 in helping adults quit smoking cigarettes. AXS-05 contains a combination of medicines called dextromethorphan and bupropion. AXS-05 is an investigational medication for smoking cessation. This means it has not been approved by the FDA for use in smoking cessation.
The study has three medication groups and is randomized. Participants will be randomly assigned to the groups and will have a 1 in 3 chance of taking either AXS-05, bupropion alone, or a placebo. The bupropion and placebo pills look exactly like AXS-05, but don’t contain AXS-05. The study is also blinded. This means that the study doctor, staff, and participants do not know who is taking which study medication.
Study participation may last about 6-7 months and include a mix of in-clinic and remote visits. During the study, each participant’s overall health will be monitored by a team of physicians and study staff. Eligible participants will receive study-related care and evaluations at no cost. Compensation for time and travel may be available.
What to Expect
If you are eligible and choose to participate in the SUMMIT study, participation will last approximtely 6-7 months and includes both in-person and remote visits. It is important to understand how many visits you will need to attend when making the decision to participate.
Screening Period
This is the time when the study doctor and staff determine if you are eligible for the study. You will come in for the first visit to answer some questions and do some medical tests to see if you may be a good fit for the study. Participants will also complete a daily electronic diary to report their smoking status during the Screening Period.
Treatment Period
If you are eligible to continue in the study, you will then enter the treatment period, which has a mix of both in-person and remote visits.
Participants will be randomly assigned to take either AXS-05, bupropion alone, or placebo. The study doctor and staff do not know who is assigned to which study medication.
Follow-Up Period
In the Follow-Up Period, the study doctor and staff will continue to monitor your smoking status and how you feel. Participants do not take any study medication during this period.
At the in-person visits, you can expect some of the following assessments:
Vital Signs
ECG
Review of Medical History
Blood and Urine Samples
Health Questionnaires
Review of Any Side Effects
Why Participate?

If you’re a cigarette smoker looking to quit, the SUMMIT study may be right for you. If you are eligible to participate:
- You may receive the investigational medicine
- You may receive study-related care and study evaluations at no cost
- You may receive compensation for your time and travel
- You may have the opportunity to help advance potential new treatments for smoking cessation*.
About Smoking Cessation
Although smoking rates continue to decrease, smoking remains the leading cause of preventable disease and death in the United States.1 Using tobacco, the substance that contains the addictive chemical, nicotine, can lead to serious health problems.
Smoking cessation, or quitting smoking, is associated with positive health effects in adults of all ages. When people stop smoking, they can experience a better quality of life and lower the risk of cancer, heart, and lung disease.2
Currently, the use of medication remains the main form of treatment for smoking cessation. Quitting smoking can be difficult, but it can be achieved. You don’t have to do it alone.

References
1. Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco Product Use Among Adults - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742. doi: 10.15585/mmwr.mm6946a4. PMID: 33211681; PMCID: PMC7676638.
2. Centers for Disease Control and Prevention. (2024). Benefits of quitting smoking. Centers for Disease Control and Prevention. https://www.cdc.gov/tobacco/about/benefits-of-quitting.html
Smoking Cessation Resources
FAQs
A clinical research study, also called a clinical trial, tests the safety and efficacy of an investigational medicine in human volunteers. Every medication on the market has gone through this process, meaning volunteers are an important part of advancing medicine for present and future generations.
AXS-05 is the investigational oral medicine being researched in this study. In this study, researchers want to know if AXS-05 can help adults quit smoking cigarettes. It is an investigational treatment, meaning it has not been approved by any health authority for use in smoking cessation.
Clinical studies can be sponsored, or funded, by a pharmaceutical or biotechnology company, academic medical center, or health care provider. Every clinical study is held at one or more sites that are led by a principal investigator (study doctor) and their research team.
A placebo looks like the investigational medicine but does not contain any active ingredients (medicine). Taking placebo is as if the participant was not taking anything at all. In this study, placebo is used to compare the effects of the investigational medicine. Neither the participant nor the study doctor will know if they are taking the investigational medicine or placebo. In case of a medical emergency, the study doctor will be able to find out which group the participant belongs to.
In order to participate in a study, you will need to first take some tests and discuss your medical history with the study doctor to ensure that you meet all criteria for participation. You will also review and sign an informed consent form which lays out what will happen in the study, your rights and responsibilities as a participant, and the risks and potential benefits of the study. Once you are eligible and enrolled, you will visit the study site regularly to monitor your progress and overall health. Yes, study participation is absolutely voluntary. You have the right to end participation at any time for any reason. In case you decide to drop out of the study, please speak with the study doctor first.
For more information about the study, visit https://clinicaltrials.gov/study/NCT07766655. For more information about Axsome Therapeutics, the study sponsor, visit axsome.com.
